News

News

News

tinniwell app with external in-ears launches in the first quarter of 2026 – DiGA listing planned in Germany

Oct 3, 2025

tinniwell app with external in-ears launches in the first quarter of 2026 – DiGA listing planned in Germany

Oct 3, 2025

tinniwell app with external in-ears launches in the first quarter of 2026 – DiGA listing planned in Germany

Oct 3, 2025

tinniwell® shows breakthrough in migraine therapy

Aug 22, 2025

tinniwell® shows breakthrough in migraine therapy

Aug 22, 2025

tinniwell® shows breakthrough in migraine therapy

Aug 22, 2025

Tinnitus in the Focus of Research:

Jul 23, 2025

Tinnitus in the Focus of Research:

Jul 23, 2025

Tinnitus in the Focus of Research:

Jul 23, 2025

tinniwell use increases by over 900%

Jun 2, 2025

tinniwell use increases by over 900%

Jun 2, 2025

tinniwell use increases by over 900%

Jun 2, 2025

Apple Hearing Study confirms: Tinnitus is widespread

May 5, 2025

Apple Hearing Study confirms: Tinnitus is widespread

May 5, 2025

Apple Hearing Study confirms: Tinnitus is widespread

May 5, 2025

Resaphene reaches an important milestone

Feb 25, 2025

Resaphene reaches an important milestone

Feb 25, 2025

Resaphene reaches an important milestone

Feb 25, 2025

Preparations for the double-blind study are starting

Jan 21, 2025

Preparations for the double-blind study are starting

Jan 21, 2025

Preparations for the double-blind study are starting

Jan 21, 2025

Market entry in India is imminent

Dec 4, 2024

Market entry in India is imminent

Dec 4, 2024

Market entry in India is imminent

Dec 4, 2024

Exclusive distribution contract for tinniwell in Turkey

Sep 25, 2024

Exclusive distribution contract for tinniwell in Turkey

Sep 25, 2024

Exclusive distribution contract for tinniwell in Turkey

Sep 25, 2024

Multiplication of the tinniwell sales

Jun 3, 2024

Multiplication of the tinniwell sales

Jun 3, 2024

Multiplication of the tinniwell sales

Jun 3, 2024

Demand for tinniwell increases monthly by about 10%

Feb 6, 2024

Demand for tinniwell increases monthly by about 10%

Feb 6, 2024

Demand for tinniwell increases monthly by about 10%

Feb 6, 2024

Ninth series of the tinniwell produced for the European market

Jan 25, 2024

Ninth series of the tinniwell produced for the European market

Jan 25, 2024

Ninth series of the tinniwell produced for the European market

Jan 25, 2024

Brain implant for tinnitus is not coming after all

Oct 17, 2023

Brain implant for tinnitus is not coming after all

Oct 17, 2023

Brain implant for tinnitus is not coming after all

Oct 17, 2023

Increasing the linear temperature shows a significant effect

Aug 15, 2023

Increasing the linear temperature shows a significant effect

Aug 15, 2023

Increasing the linear temperature shows a significant effect

Aug 15, 2023

First series of tinniwell produced for the Chinese market

May 9, 2023

First series of tinniwell produced for the Chinese market

May 9, 2023

First series of tinniwell produced for the Chinese market

May 9, 2023

Contract for exclusive distribution of tinniwell in China signed

Apr 2, 2023

Contract for exclusive distribution of tinniwell in China signed

Apr 2, 2023

Contract for exclusive distribution of tinniwell in China signed

Apr 2, 2023

tinniwell is the market leader in tinnitus therapy

Feb 8, 2023

tinniwell is the market leader in tinnitus therapy

Feb 8, 2023

tinniwell is the market leader in tinnitus therapy

Feb 8, 2023

Demand for tinniwell increases by 76%

Nov 7, 2022

Demand for tinniwell increases by 76%

Nov 7, 2022

Demand for tinniwell increases by 76%

Nov 7, 2022

Brain blood flow influences the severity of tinnitus.

Sep 26, 2022

Brain blood flow influences the severity of tinnitus.

Sep 26, 2022

Brain blood flow influences the severity of tinnitus.

Sep 26, 2022

The FDA approval process for the tinnitus therapy tinniwell is continuing.

Jul 13, 2022

The FDA approval process for the tinnitus therapy tinniwell is continuing.

Jul 13, 2022

The FDA approval process for the tinnitus therapy tinniwell is continuing.

Jul 13, 2022

Long COVID multiplies the revenue of tinniwell

May 20, 2022

Long COVID multiplies the revenue of tinniwell

May 20, 2022

Long COVID multiplies the revenue of tinniwell

May 20, 2022

Framework agreement for the delivery of 2,000 pieces of tinniwell concluded

Mar 7, 2022

Framework agreement for the delivery of 2,000 pieces of tinniwell concluded

Mar 7, 2022

Framework agreement for the delivery of 2,000 pieces of tinniwell concluded

Mar 7, 2022

2nd contract manufacturer produces 6th series of the tinniwell

Feb 28, 2022

2nd contract manufacturer produces 6th series of the tinniwell

Feb 28, 2022

2nd contract manufacturer produces 6th series of the tinniwell

Feb 28, 2022

Production capacities are being expanded – tinnitus is a common consequence of a COVID-19 infection

Jan 2, 2022

Production capacities are being expanded – tinnitus is a common consequence of a COVID-19 infection

Jan 2, 2022

Production capacities are being expanded – tinnitus is a common consequence of a COVID-19 infection

Jan 2, 2022

tinniwell shows very good effects in migraine patients

Oct 25, 2021

tinniwell shows very good effects in migraine patients

Oct 25, 2021

tinniwell shows very good effects in migraine patients

Oct 25, 2021

Due to high demand, the 5th series of tinniwell will be produced earlier.

Jul 26, 2021

Due to high demand, the 5th series of tinniwell will be produced earlier.

Jul 26, 2021

Due to high demand, the 5th series of tinniwell will be produced earlier.

Jul 26, 2021

tinniwell 2.0 goes into production

May 6, 2021

tinniwell 2.0 goes into production

May 6, 2021

tinniwell 2.0 goes into production

May 6, 2021

New packaging for the tinniwell

Feb 8, 2021

New packaging for the tinniwell

Feb 8, 2021

New packaging for the tinniwell

Feb 8, 2021

Approval procedures changed at the FDA

Dec 16, 2020

Approval procedures changed at the FDA

Dec 16, 2020

Approval procedures changed at the FDA

Dec 16, 2020

The study on tinniwell is delayed due to COVID-19.

Nov 12, 2020

The study on tinniwell is delayed due to COVID-19.

Nov 12, 2020

The study on tinniwell is delayed due to COVID-19.

Nov 12, 2020

Production of the 4th series of tinniwell has started

Nov 10, 2020

Production of the 4th series of tinniwell has started

Nov 10, 2020

Production of the 4th series of tinniwell has started

Nov 10, 2020

Tinnitus: 4 phases to healing with Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell

May 18, 2020

Tinnitus: 4 phases to healing with Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell

May 18, 2020

Tinnitus: 4 phases to healing with Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell

May 18, 2020

Work has started on the FDA approval of tinniwell

May 15, 2020

Work has started on the FDA approval of tinniwell

May 15, 2020

Work has started on the FDA approval of tinniwell

May 15, 2020

Resaphene Suisse AG announces the cancellation of the securitization of the shares

Apr 28, 2020

Resaphene Suisse AG announces the cancellation of the securitization of the shares

Apr 28, 2020

Resaphene Suisse AG announces the cancellation of the securitization of the shares

Apr 28, 2020

Resaphene Suisse AG has announced the withdrawal of its inclusion in the Vienna MTF at the Vienna Stock Exchange.

Mar 31, 2020

Resaphene Suisse AG has announced the withdrawal of its inclusion in the Vienna MTF at the Vienna Stock Exchange.

Mar 31, 2020

Resaphene Suisse AG has announced the withdrawal of its inclusion in the Vienna MTF at the Vienna Stock Exchange.

Mar 31, 2020

Ethics committee of Charité in Berlin approves study on tinnitus therapy tinniwell

Jan 21, 2020

Ethics committee of Charité in Berlin approves study on tinnitus therapy tinniwell

Jan 21, 2020

Ethics committee of Charité in Berlin approves study on tinnitus therapy tinniwell

Jan 21, 2020

Expansion to North America

Feb 20, 2019

Expansion to North America

Feb 20, 2019

Expansion to North America

Feb 20, 2019

Resaphene Suisse AG announces patent on tinniwell

Feb 4, 2019

Resaphene Suisse AG announces patent on tinniwell

Feb 4, 2019

Resaphene Suisse AG announces patent on tinniwell

Feb 4, 2019

Tinniwell receives patent in the USA

Dec 8, 2018

Tinniwell receives patent in the USA

Dec 8, 2018

Tinniwell receives patent in the USA

Dec 8, 2018

Tinniwell is covered by health insurance companies

Nov 8, 2018

Tinniwell is covered by health insurance companies

Nov 8, 2018

Tinniwell is covered by health insurance companies

Nov 8, 2018

Cooperation with GEHE Pharma Trade

Aug 4, 2018

Cooperation with GEHE Pharma Trade

Aug 4, 2018

Cooperation with GEHE Pharma Trade

Aug 4, 2018

Resaphene Suisse AG is going public

Jun 21, 2018

Resaphene Suisse AG is going public

Jun 21, 2018

Resaphene Suisse AG is going public

Jun 21, 2018

Test winner: tinniwell impresses in comparison test of tinnitus therapy systems

Feb 28, 2018

Test winner: tinniwell impresses in comparison test of tinnitus therapy systems

Feb 28, 2018

Test winner: tinniwell impresses in comparison test of tinnitus therapy systems

Feb 28, 2018

New state company at Resaphene

Jan 4, 2018

New state company at Resaphene

Jan 4, 2018

New state company at Resaphene

Jan 4, 2018